PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20077811-5	2010	The relief from pelvic pain achieved with a gonadotropin-releasing hormone agonist can be sustained by long-term administration of a tapered dose of danazol or medium-to-low doses of oral contraceptives.	Danazol	149-156	gonadotropin releasing hormone 1	Homo sapiens	44-74	
7926243-5	1994	RESULTS: GnRH-stimulated gonadotropin response during danazol treatment was significantly higher than that in the same group of women before and after danazol treatment, as well as in controls.	Danazol	54-61	gonadotropin releasing hormone 1	Homo sapiens	9-13	
15213601-3	2004	The expression of ER and bcl-2 was weaker in the adenomyotic endometrium treated with danazol than in that treated with gonadotro-pin-releasing hormone agonist (GnRHa), whereas bcl-2 phosphorylated on serine-87 was more intensely expressed in danazol-treated adenomyotic endometrium than in the GnRHa-treated one.	Danazol	86-93	gonadotropin releasing hormone 1	Homo sapiens	120-151	
12917884-18	2003	The odds ratio for pregnancy following all agents versus danazol, the most commonly used agent prior to the advent of gonadotropin releasing hormone agonists (GnRHa), was 1.3 (95% CI 0.97 to 1.76).	Danazol	57-64	gonadotropin releasing hormone 1	Homo sapiens	118-148	
11216879-6	2001	RESULTS: Our results show that danazol concentrations (10(-7) -10(-5) M), taking into account the therapeutic levels found in the plasma of treated patients, inhibited MCP-1 protein and mRNA steady-state levels in endometriotic cells, whereas buserelin acetate (0.1-10 ng/mL), a GnRH agonist, had no significant effect.	Danazol	31-38	gonadotropin releasing hormone 1	Homo sapiens	279-283	
19803901-2	2006	Gonadotropin-releasing hormone analogs such as danazol, progestogens and estrogen-progestin combinations have all proven effective in relieving pain and reducing the extent of endometriotic implants.	Danazol	47-54	gonadotropin releasing hormone 1	Homo sapiens	0-30	
7926243-5	1994	RESULTS: GnRH-stimulated gonadotropin response during danazol treatment was significantly higher than that in the same group of women before and after danazol treatment, as well as in controls.	Danazol	151-158	gonadotropin releasing hormone 1	Homo sapiens	9-13	
2530291-1	1989	GnRH agonist and synthetic steroid such as Danazol, Medroxyprogesterone acetate (MPA) and Gestrinone are useful for the treatment of patients with endometriosis.	Danazol	43-50	gonadotropin releasing hormone 1	Homo sapiens	0-4	
2120647-7	1990	Gonadotropin-releasing hormone agonist therapy may be an important therapeutic alternative for women with pulmonary endometriosis who cannot tolerate danazol treatment and in whom surgical therapy fails to relieve the chest symptoms.	Danazol	150-157	gonadotropin releasing hormone 1	Homo sapiens	0-30	
6437127-1	1984	The purpose of this investigation was to study the influence of danazol on the basal levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), on their response to gonadotropin-releasing hormone (GnRH), as well as the effect of different doses on the serum levels of prolactin, estradiol and progesterone.	Danazol	64-71	gonadotropin releasing hormone 1	Homo sapiens	181-211	
6437127-1	1984	The purpose of this investigation was to study the influence of danazol on the basal levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), on their response to gonadotropin-releasing hormone (GnRH), as well as the effect of different doses on the serum levels of prolactin, estradiol and progesterone.	Danazol	64-71	gonadotropin releasing hormone 1	Homo sapiens	213-217	
6437127-7	1984	The pituitary responsiveness to GnRH was significantly higher during danazol treatment, than found during the early follicular phase.	Danazol	69-76	gonadotropin releasing hormone 1	Homo sapiens	32-36	
6818119-5	1982	During Danazol treatment 200 mg daily for 6 months basal gonadotropin levels, the sleep related hormone increases as well as the response to luteinizing-hormone releasing hormone (LHRH) stimulation were blunted.	Danazol	7-14	gonadotropin releasing hormone 1	Homo sapiens	141-178	
6818119-5	1982	During Danazol treatment 200 mg daily for 6 months basal gonadotropin levels, the sleep related hormone increases as well as the response to luteinizing-hormone releasing hormone (LHRH) stimulation were blunted.	Danazol	7-14	gonadotropin releasing hormone 1	Homo sapiens	180-184